Serotonin syndrome.
- 1 January 2013
- journal article
- review article
- Vol. 13 (4), 533-40
Abstract
Serotonin syndrome is a potentially life-threatening syndrome that is precipitated by the use of serotonergic drugs and overactivation of both the peripheral and central postsynaptic 5HT-1A and, most notably, 5HT-2A receptors. This syndrome consists of a combination of mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity. Serotonin syndrome can occur via the therapeutic use of serotonergic drugs alone, an intentional overdose of serotonergic drugs, or classically, as a result of a complex drug interaction between two serotonergic drugs that work by different mechanisms. A multitude of drug combinations can result in serotonin syndrome. This review describes the presentation and management of serotonin syndrome and discusses the drugs and interactions that can precipitate this syndrome with the goal of making physicians more alert and aware of this potentially fatal yet preventable syndrome. Many commonly used medications have proven to be the culprits of serotonin syndrome. Proper education and awareness about serotonin syndrome will improve the accuracy of diagnosis and promote the institution of the appropriate treatment that may prevent significant morbidity and mortality.Keywords
This publication has 23 references indexed in Scilit:
- Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression.2011
- Prevention, recognition, and management of serotonin syndrome.2010
- Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative deliriumJournal of Psychopharmacology, 2009
- Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient miceNeuropharmacology, 2007
- The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicityQJM: An International Journal of Medicine, 2003
- Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndromeNeurochemistry International, 2003
- Potent serotonin (5-HT)2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndromeBrain Research, 2001
- Risperidone counteracts lethality in an animal model of the serotonin syndromePsychopharmacology, 2000
- Serotonin Syndrome During Treatment With Paroxetine and RisperidoneJournal of Clinical Psychopharmacology, 2000
- Possible Serotonin Syndrome Associated with Tramadol and Sertraline CoadministrationAnnals of Pharmacotherapy, 1997